Antibiotics-Global Market Status and Trend Report 2013-2023
Report Summary
Antibiotics-Global Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Antibiotics industry, standing on the readers? perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Regional Market Size of Antibiotics 2013-2017, and development forecast 2018-2023
Main manufacturers/suppliers of Antibiotics worldwide, with company and product introduction, position in the Antibiotics market
Market status and development trend of Antibiotics by types and applications
Cost and profit status of Antibiotics, and marketing status
Market growth drivers and challenges
The report segments the global Antibiotics market as:
Global Antibiotics Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
North America
Europe
China
Japan
Rest APAC
Latin America
Global Antibiotics Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
?- lactam
Macrolides
Aminoglycosides
Others
Global Antibiotics Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Clinics
Hospitals
Others
Global Antibiotics Market: Manufacturers Segment Analysis (Company and Product introduction, Antibiotics Sales Volume, Revenue, Price and Gross Margin):
Pfizer
Novartis
Sanofi?
Roche
Merck
GSK
Johnson & Johnson
AstraZeneca
Eli Lilly
AbbVie
Bayer
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Antibiotics-Global Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Antibiotics industry, standing on the readers? perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Regional Market Size of Antibiotics 2013-2017, and development forecast 2018-2023
Main manufacturers/suppliers of Antibiotics worldwide, with company and product introduction, position in the Antibiotics market
Market status and development trend of Antibiotics by types and applications
Cost and profit status of Antibiotics, and marketing status
Market growth drivers and challenges
The report segments the global Antibiotics market as:
Global Antibiotics Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
North America
Europe
China
Japan
Rest APAC
Latin America
Global Antibiotics Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
?- lactam
Macrolides
Aminoglycosides
Others
Global Antibiotics Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Clinics
Hospitals
Others
Global Antibiotics Market: Manufacturers Segment Analysis (Company and Product introduction, Antibiotics Sales Volume, Revenue, Price and Gross Margin):
Pfizer
Novartis
Sanofi?
Roche
Merck
GSK
Johnson & Johnson
AstraZeneca
Eli Lilly
AbbVie
Bayer
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF ANTIBIOTICS
1.1 Definition of Antibiotics in This Report
1.2 Commercial Types of Antibiotics
1.2.1 ?- lactam
1.2.2 Macrolides
1.2.3 Aminoglycosides
1.2.4 Others
1.3 Downstream Application of Antibiotics
1.3.1 Clinics
1.3.2 Hospitals
1.3.3 Others
1.4 Development History of Antibiotics
1.5 Market Status and Trend of Antibiotics 2013-2023
1.5.1 Global Antibiotics Market Status and Trend 2013-2023
1.5.2 Regional Antibiotics Market Status and Trend 2013-2023
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Antibiotics 2013-2017
2.2 Sales Market of Antibiotics by Regions
2.2.1 Sales Volume of Antibiotics by Regions
2.2.2 Sales Value of Antibiotics by Regions
2.3 Production Market of Antibiotics by Regions
2.4 Global Market Forecast of Antibiotics 2018-2023
2.4.1 Global Market Forecast of Antibiotics 2018-2023
2.4.2 Market Forecast of Antibiotics by Regions 2018-2023
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Sales Volume of Antibiotics by Types
3.2 Sales Value of Antibiotics by Types
3.3 Market Forecast of Antibiotics by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Global Sales Volume of Antibiotics by Downstream Industry
4.2 Global Market Forecast of Antibiotics by Downstream Industry
CHAPTER 5 NORTH AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
5.1 North America Antibiotics Market Status by Countries
5.1.1 North America Antibiotics Sales by Countries (2013-2017)
5.1.2 North America Antibiotics Revenue by Countries (2013-2017)
5.1.3 United States Antibiotics Market Status (2013-2017)
5.1.4 Canada Antibiotics Market Status (2013-2017)
5.1.5 Mexico Antibiotics Market Status (2013-2017)
5.2 North America Antibiotics Market Status by Manufacturers
5.3 North America Antibiotics Market Status by Type (2013-2017)
5.3.1 North America Antibiotics Sales by Type (2013-2017)
5.3.2 North America Antibiotics Revenue by Type (2013-2017)
5.4 North America Antibiotics Market Status by Downstream Industry (2013-2017)
CHAPTER 6 EUROPE MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
6.1 Europe Antibiotics Market Status by Countries
6.1.1 Europe Antibiotics Sales by Countries (2013-2017)
6.1.2 Europe Antibiotics Revenue by Countries (2013-2017)
6.1.3 Germany Antibiotics Market Status (2013-2017)
6.1.4 UK Antibiotics Market Status (2013-2017)
6.1.5 France Antibiotics Market Status (2013-2017)
6.1.6 Italy Antibiotics Market Status (2013-2017)
6.1.7 Russia Antibiotics Market Status (2013-2017)
6.1.8 Spain Antibiotics Market Status (2013-2017)
6.1.9 Benelux Antibiotics Market Status (2013-2017)
6.2 Europe Antibiotics Market Status by Manufacturers
6.3 Europe Antibiotics Market Status by Type (2013-2017)
6.3.1 Europe Antibiotics Sales by Type (2013-2017)
6.3.2 Europe Antibiotics Revenue by Type (2013-2017)
6.4 Europe Antibiotics Market Status by Downstream Industry (2013-2017)
CHAPTER 7 ASIA PACIFIC MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
7.1 Asia Pacific Antibiotics Market Status by Countries
7.1.1 Asia Pacific Antibiotics Sales by Countries (2013-2017)
7.1.2 Asia Pacific Antibiotics Revenue by Countries (2013-2017)
7.1.3 China Antibiotics Market Status (2013-2017)
7.1.4 Japan Antibiotics Market Status (2013-2017)
7.1.5 India Antibiotics Market Status (2013-2017)
7.1.6 Southeast Asia Antibiotics Market Status (2013-2017)
7.1.7 Australia Antibiotics Market Status (2013-2017)
7.2 Asia Pacific Antibiotics Market Status by Manufacturers
7.3 Asia Pacific Antibiotics Market Status by Type (2013-2017)
7.3.1 Asia Pacific Antibiotics Sales by Type (2013-2017)
7.3.2 Asia Pacific Antibiotics Revenue by Type (2013-2017)
7.4 Asia Pacific Antibiotics Market Status by Downstream Industry (2013-2017)
CHAPTER 8 LATIN AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
8.1 Latin America Antibiotics Market Status by Countries
8.1.1 Latin America Antibiotics Sales by Countries (2013-2017)
8.1.2 Latin America Antibiotics Revenue by Countries (2013-2017)
8.1.3 Brazil Antibiotics Market Status (2013-2017)
8.1.4 Argentina Antibiotics Market Status (2013-2017)
8.1.5 Colombia Antibiotics Market Status (2013-2017)
8.2 Latin America Antibiotics Market Status by Manufacturers
8.3 Latin America Antibiotics Market Status by Type (2013-2017)
8.3.1 Latin America Antibiotics Sales by Type (2013-2017)
8.3.2 Latin America Antibiotics Revenue by Type (2013-2017)
8.4 Latin America Antibiotics Market Status by Downstream Industry (2013-2017)
CHAPTER 9 MIDDLE EAST AND AFRICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
9.1 Middle East and Africa Antibiotics Market Status by Countries
9.1.1 Middle East and Africa Antibiotics Sales by Countries (2013-2017)
9.1.2 Middle East and Africa Antibiotics Revenue by Countries (2013-2017)
9.1.3 Middle East Antibiotics Market Status (2013-2017)
9.1.4 Africa Antibiotics Market Status (2013-2017)
9.2 Middle East and Africa Antibiotics Market Status by Manufacturers
9.3 Middle East and Africa Antibiotics Market Status by Type (2013-2017)
9.3.1 Middle East and Africa Antibiotics Sales by Type (2013-2017)
9.3.2 Middle East and Africa Antibiotics Revenue by Type (2013-2017)
9.4 Middle East and Africa Antibiotics Market Status by Downstream Industry (2013-2017)
CHAPTER 10 MARKET DRIVING FACTOR ANALYSIS OF ANTIBIOTICS
10.1 Global Economy Situation and Trend Overview
10.2 Antibiotics Downstream Industry Situation and Trend Overview
CHAPTER 11 ANTIBIOTICS MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
11.1 Production Volume of Antibiotics by Major Manufacturers
11.2 Production Value of Antibiotics by Major Manufacturers
11.3 Basic Information of Antibiotics by Major Manufacturers
11.3.1 Headquarters Location and Established Time of Antibiotics Major Manufacturer
11.3.2 Employees and Revenue Level of Antibiotics Major Manufacturer
11.4 Market Competition News and Trend
11.4.1 Merger, Consolidation or Acquisition News
11.4.2 Investment or Disinvestment News
11.4.3 New Product Development and Launch
CHAPTER 12 ANTIBIOTICS MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
12.1 Pfizer
12.1.1 Company profile
12.1.2 Representative Antibiotics Product
12.1.3 Antibiotics Sales, Revenue, Price and Gross Margin of Pfizer
12.2 Novartis
12.2.1 Company profile
12.2.2 Representative Antibiotics Product
12.2.3 Antibiotics Sales, Revenue, Price and Gross Margin of Novartis
12.3 Sanofi?
12.3.1 Company profile
12.3.2 Representative Antibiotics Product
12.3.3 Antibiotics Sales, Revenue, Price and Gross Margin of Sanofi?
12.4 Roche
12.4.1 Company profile
12.4.2 Representative Antibiotics Product
12.4.3 Antibiotics Sales, Revenue, Price and Gross Margin of Roche
12.5 Merck
12.5.1 Company profile
12.5.2 Representative Antibiotics Product
12.5.3 Antibiotics Sales, Revenue, Price and Gross Margin of Merck
12.6 GSK
12.6.1 Company profile
12.6.2 Representative Antibiotics Product
12.6.3 Antibiotics Sales, Revenue, Price and Gross Margin of GSK
12.7 Johnson & Johnson
12.7.1 Company profile
12.7.2 Representative Antibiotics Product
12.7.3 Antibiotics Sales, Revenue, Price and Gross Margin of Johnson & Johnson
12.8 AstraZeneca
12.8.1 Company profile
12.8.2 Representative Antibiotics Product
12.8.3 Antibiotics Sales, Revenue, Price and Gross Margin of AstraZeneca
12.9 Eli Lilly
12.9.1 Company profile
12.9.2 Representative Antibiotics Product
12.9.3 Antibiotics Sales, Revenue, Price and Gross Margin of Eli Lilly
12.10 AbbVie
12.10.1 Company profile
12.10.2 Representative Antibiotics Product
12.10.3 Antibiotics Sales, Revenue, Price and Gross Margin of AbbVie
12.11 Bayer
12.11.1 Company profile
12.11.2 Representative Antibiotics Product
12.11.3 Antibiotics Sales, Revenue, Price and Gross Margin of Bayer
CHAPTER 13 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF ANTIBIOTICS
13.1 Industry Chain of Antibiotics
13.2 Upstream Market and Representative Companies Analysis
13.3 Downstream Market and Representative Companies Analysis
CHAPTER 14 COST AND GROSS MARGIN ANALYSIS OF ANTIBIOTICS
14.1 Cost Structure Analysis of Antibiotics
14.2 Raw Materials Cost Analysis of Antibiotics
14.3 Labor Cost Analysis of Antibiotics
14.4 Manufacturing Expenses Analysis of Antibiotics
CHAPTER 15 REPORT CONCLUSION
CHAPTER 16 RESEARCH METHODOLOGY AND REFERENCE
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Reference
1.1 Definition of Antibiotics in This Report
1.2 Commercial Types of Antibiotics
1.2.1 ?- lactam
1.2.2 Macrolides
1.2.3 Aminoglycosides
1.2.4 Others
1.3 Downstream Application of Antibiotics
1.3.1 Clinics
1.3.2 Hospitals
1.3.3 Others
1.4 Development History of Antibiotics
1.5 Market Status and Trend of Antibiotics 2013-2023
1.5.1 Global Antibiotics Market Status and Trend 2013-2023
1.5.2 Regional Antibiotics Market Status and Trend 2013-2023
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Antibiotics 2013-2017
2.2 Sales Market of Antibiotics by Regions
2.2.1 Sales Volume of Antibiotics by Regions
2.2.2 Sales Value of Antibiotics by Regions
2.3 Production Market of Antibiotics by Regions
2.4 Global Market Forecast of Antibiotics 2018-2023
2.4.1 Global Market Forecast of Antibiotics 2018-2023
2.4.2 Market Forecast of Antibiotics by Regions 2018-2023
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Sales Volume of Antibiotics by Types
3.2 Sales Value of Antibiotics by Types
3.3 Market Forecast of Antibiotics by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Global Sales Volume of Antibiotics by Downstream Industry
4.2 Global Market Forecast of Antibiotics by Downstream Industry
CHAPTER 5 NORTH AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
5.1 North America Antibiotics Market Status by Countries
5.1.1 North America Antibiotics Sales by Countries (2013-2017)
5.1.2 North America Antibiotics Revenue by Countries (2013-2017)
5.1.3 United States Antibiotics Market Status (2013-2017)
5.1.4 Canada Antibiotics Market Status (2013-2017)
5.1.5 Mexico Antibiotics Market Status (2013-2017)
5.2 North America Antibiotics Market Status by Manufacturers
5.3 North America Antibiotics Market Status by Type (2013-2017)
5.3.1 North America Antibiotics Sales by Type (2013-2017)
5.3.2 North America Antibiotics Revenue by Type (2013-2017)
5.4 North America Antibiotics Market Status by Downstream Industry (2013-2017)
CHAPTER 6 EUROPE MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
6.1 Europe Antibiotics Market Status by Countries
6.1.1 Europe Antibiotics Sales by Countries (2013-2017)
6.1.2 Europe Antibiotics Revenue by Countries (2013-2017)
6.1.3 Germany Antibiotics Market Status (2013-2017)
6.1.4 UK Antibiotics Market Status (2013-2017)
6.1.5 France Antibiotics Market Status (2013-2017)
6.1.6 Italy Antibiotics Market Status (2013-2017)
6.1.7 Russia Antibiotics Market Status (2013-2017)
6.1.8 Spain Antibiotics Market Status (2013-2017)
6.1.9 Benelux Antibiotics Market Status (2013-2017)
6.2 Europe Antibiotics Market Status by Manufacturers
6.3 Europe Antibiotics Market Status by Type (2013-2017)
6.3.1 Europe Antibiotics Sales by Type (2013-2017)
6.3.2 Europe Antibiotics Revenue by Type (2013-2017)
6.4 Europe Antibiotics Market Status by Downstream Industry (2013-2017)
CHAPTER 7 ASIA PACIFIC MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
7.1 Asia Pacific Antibiotics Market Status by Countries
7.1.1 Asia Pacific Antibiotics Sales by Countries (2013-2017)
7.1.2 Asia Pacific Antibiotics Revenue by Countries (2013-2017)
7.1.3 China Antibiotics Market Status (2013-2017)
7.1.4 Japan Antibiotics Market Status (2013-2017)
7.1.5 India Antibiotics Market Status (2013-2017)
7.1.6 Southeast Asia Antibiotics Market Status (2013-2017)
7.1.7 Australia Antibiotics Market Status (2013-2017)
7.2 Asia Pacific Antibiotics Market Status by Manufacturers
7.3 Asia Pacific Antibiotics Market Status by Type (2013-2017)
7.3.1 Asia Pacific Antibiotics Sales by Type (2013-2017)
7.3.2 Asia Pacific Antibiotics Revenue by Type (2013-2017)
7.4 Asia Pacific Antibiotics Market Status by Downstream Industry (2013-2017)
CHAPTER 8 LATIN AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
8.1 Latin America Antibiotics Market Status by Countries
8.1.1 Latin America Antibiotics Sales by Countries (2013-2017)
8.1.2 Latin America Antibiotics Revenue by Countries (2013-2017)
8.1.3 Brazil Antibiotics Market Status (2013-2017)
8.1.4 Argentina Antibiotics Market Status (2013-2017)
8.1.5 Colombia Antibiotics Market Status (2013-2017)
8.2 Latin America Antibiotics Market Status by Manufacturers
8.3 Latin America Antibiotics Market Status by Type (2013-2017)
8.3.1 Latin America Antibiotics Sales by Type (2013-2017)
8.3.2 Latin America Antibiotics Revenue by Type (2013-2017)
8.4 Latin America Antibiotics Market Status by Downstream Industry (2013-2017)
CHAPTER 9 MIDDLE EAST AND AFRICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
9.1 Middle East and Africa Antibiotics Market Status by Countries
9.1.1 Middle East and Africa Antibiotics Sales by Countries (2013-2017)
9.1.2 Middle East and Africa Antibiotics Revenue by Countries (2013-2017)
9.1.3 Middle East Antibiotics Market Status (2013-2017)
9.1.4 Africa Antibiotics Market Status (2013-2017)
9.2 Middle East and Africa Antibiotics Market Status by Manufacturers
9.3 Middle East and Africa Antibiotics Market Status by Type (2013-2017)
9.3.1 Middle East and Africa Antibiotics Sales by Type (2013-2017)
9.3.2 Middle East and Africa Antibiotics Revenue by Type (2013-2017)
9.4 Middle East and Africa Antibiotics Market Status by Downstream Industry (2013-2017)
CHAPTER 10 MARKET DRIVING FACTOR ANALYSIS OF ANTIBIOTICS
10.1 Global Economy Situation and Trend Overview
10.2 Antibiotics Downstream Industry Situation and Trend Overview
CHAPTER 11 ANTIBIOTICS MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
11.1 Production Volume of Antibiotics by Major Manufacturers
11.2 Production Value of Antibiotics by Major Manufacturers
11.3 Basic Information of Antibiotics by Major Manufacturers
11.3.1 Headquarters Location and Established Time of Antibiotics Major Manufacturer
11.3.2 Employees and Revenue Level of Antibiotics Major Manufacturer
11.4 Market Competition News and Trend
11.4.1 Merger, Consolidation or Acquisition News
11.4.2 Investment or Disinvestment News
11.4.3 New Product Development and Launch
CHAPTER 12 ANTIBIOTICS MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
12.1 Pfizer
12.1.1 Company profile
12.1.2 Representative Antibiotics Product
12.1.3 Antibiotics Sales, Revenue, Price and Gross Margin of Pfizer
12.2 Novartis
12.2.1 Company profile
12.2.2 Representative Antibiotics Product
12.2.3 Antibiotics Sales, Revenue, Price and Gross Margin of Novartis
12.3 Sanofi?
12.3.1 Company profile
12.3.2 Representative Antibiotics Product
12.3.3 Antibiotics Sales, Revenue, Price and Gross Margin of Sanofi?
12.4 Roche
12.4.1 Company profile
12.4.2 Representative Antibiotics Product
12.4.3 Antibiotics Sales, Revenue, Price and Gross Margin of Roche
12.5 Merck
12.5.1 Company profile
12.5.2 Representative Antibiotics Product
12.5.3 Antibiotics Sales, Revenue, Price and Gross Margin of Merck
12.6 GSK
12.6.1 Company profile
12.6.2 Representative Antibiotics Product
12.6.3 Antibiotics Sales, Revenue, Price and Gross Margin of GSK
12.7 Johnson & Johnson
12.7.1 Company profile
12.7.2 Representative Antibiotics Product
12.7.3 Antibiotics Sales, Revenue, Price and Gross Margin of Johnson & Johnson
12.8 AstraZeneca
12.8.1 Company profile
12.8.2 Representative Antibiotics Product
12.8.3 Antibiotics Sales, Revenue, Price and Gross Margin of AstraZeneca
12.9 Eli Lilly
12.9.1 Company profile
12.9.2 Representative Antibiotics Product
12.9.3 Antibiotics Sales, Revenue, Price and Gross Margin of Eli Lilly
12.10 AbbVie
12.10.1 Company profile
12.10.2 Representative Antibiotics Product
12.10.3 Antibiotics Sales, Revenue, Price and Gross Margin of AbbVie
12.11 Bayer
12.11.1 Company profile
12.11.2 Representative Antibiotics Product
12.11.3 Antibiotics Sales, Revenue, Price and Gross Margin of Bayer
CHAPTER 13 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF ANTIBIOTICS
13.1 Industry Chain of Antibiotics
13.2 Upstream Market and Representative Companies Analysis
13.3 Downstream Market and Representative Companies Analysis
CHAPTER 14 COST AND GROSS MARGIN ANALYSIS OF ANTIBIOTICS
14.1 Cost Structure Analysis of Antibiotics
14.2 Raw Materials Cost Analysis of Antibiotics
14.3 Labor Cost Analysis of Antibiotics
14.4 Manufacturing Expenses Analysis of Antibiotics
CHAPTER 15 REPORT CONCLUSION
CHAPTER 16 RESEARCH METHODOLOGY AND REFERENCE
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Reference
